These Vaccine Latecomers Could Still Win Big. Here's How
Pfizer and Moderna have already brought coronavirus vaccines to market. But that doesn't mean the window of opportunity is closed to others whose vaccine candidates are still in development. In this Motley Fool Live video recorded on May 28, healthcare and cannabis bureau editor and analyst Olivia Zitkus and Fool contributor Adria Cimino discuss how potential vaccine latecomers Vaxart (NASDAQ: VXRT) and Inovio (NASDAQ: INO) may eventually stand out and carve out market share.
Source Fool.com
